Showing 2,781 - 2,800 results of 3,102 for search '".gov"', query time: 0.50s Refine Results
  1. 2781
  2. 2782
  3. 2783

    Impact of online health education on attention-deficit/hyperactivity disorder screening results and parenting stress among school-aged children by Jing Tan, Wenxia Yi, Jianna Shen, Bin Peng, Min Gong, Feng Li, Li Chen

    Published 2025-01-01
    “…Individual characteristics of parents and teachers should be considered in assessments (ClinicalTrial.gov ID: NCT05231902).…”
    Get full text
    Article
  4. 2784
  5. 2785

    A novel technique of blindly positioning bronchial blockers for one-lung ventilation: a prospective, randomized, crossover study by Seihee Min, Susie Yoon, Jiwon Han, Jeong-Hwa Seo, Jae-Hyon Bahk

    Published 2025-01-01
    “…Trial registration This study was registered in ClinicalTrials.gov (NCT02981537) on December 05, 2016.…”
    Get full text
    Article
  6. 2786

    Efficacy and Acceptability of a Mobile App for Monitoring the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease Receiving Home Oxygen Therapy: Randomized Contr... by Anisbed Naranjo-Rojas, Luis Ángel Perula-de Torres, Freiser Eccehomo Cruz-Mosquera, Guillermo Molina-Recio

    Published 2025-01-01
    “…Trial RegistrationClinicalTrials NCT04820790; https://clinicaltrials.gov/study/NCT04820790 International Registered Report Identifier (IRRID)RR2-https://doi.org/10.1186/s12875-021-01450-8…”
    Get full text
    Article
  7. 2787
  8. 2788

    Enhanced antitumor activity of combined hepatic arterial infusion chemotherapy with Lenvatinib and PD-1 inhibitors in unresectable hepatocellular carcinoma: a meta-analysis by Lingling Zhao, Cheng Xu, Jiewen Deng, Yang Ni

    Published 2025-02-01
    “…This meta-analysis aims to assess whether the integration of HAIC with lenvatinib and PD-1 inhibitors (referred to as the HAIC-L-P group) leads to better treatment effectiveness and security compared to lenvatinib and PD-1 inhibitors alone (L-P group) in uHCC.MethodsAn exhaustive search of the literature was conducted, including PubMed, the Cochrane Library, Embase, ClinicalTrials.gov, and Web of Science, from the start of each database until September 2024, to ensure a thorough and up-to-date compilation of relevant studies. …”
    Get full text
    Article
  9. 2789
  10. 2790
  11. 2791
  12. 2792
  13. 2793

    Improving apgar scores and reducing perineal injuries through midwife-led quality improvements: an observational study in Uganda by Johanna Blomgren, Michael B. Wells, Dinah Amongin, Kerstin Erlandsson, John Wanyama, Diana A. Afrifa, Helena Lindgren

    Published 2025-01-01
    “…Clinical trial This study is registered on ClinicalTrials.gov as of 14th February 2022, under registration number NCT05237375.…”
    Get full text
    Article
  14. 2794
  15. 2795
  16. 2796
  17. 2797

    A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment o... by Yan Gong, James Rogers, Christian Friedrich, Sanjay Patel, Alexander Staab, Jorge Luiz Gross, Daniel Polhamus, William Gillespie, Brigitta Ursula Monz, Silke Retlich

    Published 2013-03-01
    “…Comparison of two oral dipeptidyl peptidase (DPP)-4 inhibitors, sitagliptin and linagliptin, for type 2 diabetes mellitus (T2DM) treatment was used as an example.Design Systematic review with MBMA.Data sources MEDLINE, EMBASE, http://www.ClinicalTrials.gov, Cochrane review of DPP-4 inhibitors for T2DM, sitagliptin trials on Food and Drug Administration website to December 2011 and linagliptin data from the manufacturer.Eligibility criteria for selecting studies Double-blind, randomised controlled clinical trials, ≥12 weeks’ duration, that analysed sitagliptin or linagliptin efficacies as changes in glycated haemoglobin (HbA1c) levels, in adults with T2DM and HbA1c >7%, irrespective of background medication.Model development and application A Bayesian model was fitted (Markov Chain Monte Carlo method). …”
    Get full text
    Article
  18. 2798

    Acute effect of endurance exercise on human milk insulin concentrations: a randomised cross-over study by Rebecca Lyng Holm, Mads Holmen, Md Abu Jafar Sujan, Md Abu Jafar Sujan, Guro F. Giskeødegård, Trine Moholdt, Trine Moholdt

    Published 2025-01-01
    “…Future research should determine the effect of regular exercise on insulin in human milk and potential impact for infant health outcomes.Clinical trial registrationClinicalTrials.gov, identifier NCT05042414.…”
    Get full text
    Article
  19. 2799

    Expression of lipid metabolism- related genes, body composition and inflammation: Effects of sodium butyrate supplementation in subjects with obesity by Parichehr Amiri, Seyed Ahmad Hosseini, Maryam Saghafi-Asl, Amin Akbari-Naserkiadeh, Seyedeh Asal Jenani Zavieh, Sara Arefhosseini, Samira Asghari, Neda Roshanravan

    Published 2025-01-01
    “…Taken together, NaBu supplementation could exert favorable anti-obesity effects through molecular pathways, while further research is recommended.This study was registered in Iranian Registry of Clinical Trials (https://irct.behdasht.gov.ir/user/trial/56967/view), (IRCT20190303042905N3).…”
    Get full text
    Article
  20. 2800

    Risk of diabetic ketoacidosis caused by sodium glucose cotransporter-2 inhibitors in patients with type 1 diabetes: a systematic review and network meta-analysis of randomized cont... by Ying Liu, Shiwen Yang, Aidou Jiang, Dan Zou, Zhaoyang Chen, Na Su, Na Su

    Published 2025-01-01
    “…We conducted a network meta-analysis to evaluate the incidence of DKA at different doses in the treatment of T1DM.MethodsWe searched electronic databases and clinical trial registries, including PubMed, Embase (Ovid SP), the Cochrane Central Register of Controlled Trials (Ovid SP), and ClinicalTrials.gov, for randomized controlled trials (RCTs) concerning SGLT2 inhibitors in patients with T1DM from inception to December 2023. …”
    Get full text
    Article